The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Peiotal 25 microgram/250 microgram/dose pressurised inhalation, suspension



Genetic S.p.A.PA23010/001/003

Main Information

Trade NamePeiotal 25 microgram/250 microgram/dose pressurised inhalation, suspension
Active SubstancesSalmeterol
Fluticasone propionate
Dosage FormPressurised inhalation, suspension
Licence HolderGenetic S.p.A.
Licence NumberPA23010/001/003

Group Information

ATC CodeR03AK06 salmeterol and fluticasone

Status

License statusAuthorised
Licence Issued07/01/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back